Question: A physician injected silicone into a patient for purposes of breast augmentation, but used a preparation that was labeled "not for human use." The patient experienced inflammation, burning and discoloration, and subsequently developed chronic cyst formation in the breasts. In a lawsuit against the doctor, which of the following best describes the legal consequences?
|
|
A. Assuming negligence is proven, she will be awarded both compensatory and punitive damages.
B. Punitive damages are also called hedonic damages.
C. An award for pain and suffering is an example of punitive damages.
D. Punitive damages are frequently bundled with compensatory damages in medical malpractice lawsuits.
E. In order to be awarded punitive damages, the plaintiff typically must prove that the defendant was grossly negligent, exhibiting wanton and reckless disregard of the risks.
Answer: E. Punitive damages, also called exemplary damages, are uncommon in medical malpractice actions. They are awarded only in situations where there is gross or aggravated negligence and not in ordinary negligence, where compensatory damages constitute the usual remedy. Punitive damages should not be confused with damages for pain and suffering, which are common in medical malpractice lawsuits. The latter belong in the category of non-economic or general compensatory damages, as are hedonic damages that address the value of a life lost or truncated. The above hypothetical is taken from an actual case where punitive damages were allowed by the courts because of the egregious nature of misconduct.
Punitive damages are awarded where the conduct complained of merits punishment, hence the quantum, typically large, is added onto compensatory damages. Although punishing the tortfeasor is not a stated objective of the tort system, the use of punitive damages is justified where there is a reckless, willful, or wanton disregard of the obvious risk of harm. The term "gross negligence" is sometimes used to describe this type of misconduct.
For example, evidence that a defendant had prescribed an excessive number of birth control pills (over 1,000 pills within a time period when less than 200 were sufficient) with resulting liver complications was deemed sufficient to raise the issue of gross negligence (Jackson v. Taylor). Punitive damages are typically invoked in products liability actions against large corporations, in which awards may reach the multi-million range. However, some jurisdictions statutorily disallow punitive damages altogether (for example, under the Federal Torts Claim Act).
The U.S. Supreme Court has advanced a three-prong test to determine whether punitive damages are excessive. They are the degree of reprehensibility of the defendant’s conduct; the ratio between the plaintiff’s compensatory damages and the amount of punitive damages; and the difference between the punitive award and the civil or criminal sanctions that could be imposed for comparable misconduct. In BMW of North America, Inc. v. Gore, the litigants were embroiled in a controversy over a repainted BMW car that was sold as a new vehicle without due notice to the purchaser. The jury awarded $4,000 in compensatory damages, and $2 million in punitive damages, but the U.S. Supreme Court ruled that the punitive amount was grossly excessive.
The Oncology Report
Comprehensive reports and expert commentary
on the latest advances in cancer treatment from
the world's major oncology meetings.
Past issues, click here »
| Jun 1 - 5 Chicago, IL | American Society of Clinical Oncology (ASCO): Annual Meeting |
| Jun 14 - 17 Amsterdam, | European Hematology Association (EHA): Annual Congress |
| Jun 18 - 21 Lake Tahoe, NV | American Association for Cancer Research (AACR): Pancreatic Cancer: Progress and Challenges |
| Jun 20 - 22 Milan, | European Institute of Oncology (IEO): 14th Milan Breast Cancer Conference |
| Jun 25 - 26 London, | Teenage Cancer Trust (TCT): International Conference |
| Jun 27 - 30 Barcelona, | European Society for Medical Oncology (ESMO) Conference: World Congress on Gastrointestinal Cancer |
| Jun 27 - 30 Boston, MA | American Association for Cancer Research (AACR): Chemical Systems Biology |
| Jun 28 - 30 New York, NY | Multinational Association of Supportive Care in Cancer (MASCC)/ International Society of Oral Oncology (ISOO): International Symposium |
| Jun 28 - 29 Paris, | WIN 2012 Symposium |
| Jul 7 - 10 Barcelona, | 22nd Biennial Congress of the European Association for Cancer Research |